overview
Overview
CRISPR-Cas9 is a revolutionary gene-editing technology that can be used to modify or correct precise regions of DNA to treat serious diseases.
Outil d'IASleeping Giant
CRISPR-Cas9
CRISPR-Cas9 is a revolutionary gene-editing technology that can be used to modify or correct precise regions of DNA to treat serious diseases.
shipped 2 avr. 2026aifreemium
ai
Pourquoi c'est important
1ai
Stork Quadrant
Sleeping Giant· 37/100
Has a real moat but invisible to agents. Add an MCP and you'd climb.
“CRISPR-Cas9 is not threatened by LLMs because the core capability is physical biotech, not information processing. An LLM can design sequences or explain mechanisms, but it cannot edit genes, run assays, or manufacture therapeutics. The regulatory moat (FDA approval, clinical data, manufacturing standards) is the real fortress.”
Defensibility · 67/100
- Physical-world coupling
- Regulatory moat
- Network liquidity
- Proprietary refreshing data
- High-trust catastrophic workflows
- Multi-party coordination
- Brand / community / taste
An LLM alone could replace
- LLMs cannot perform actual gene editing in living cells or organisms
- LLMs cannot conduct wet-lab experiments or synthesize biological molecules
- LLMs cannot navigate FDA approval pathways or conduct clinical trials
- LLMs cannot manufacture or deliver therapeutic treatments to patients
Agent-Readiness · 0/100
- Verified MCP
- Listed on agent surfaces
- Usage-based pricing
- Headless agent auth
- Public OpenAPI
- Active changelog
- llms.txt
How to defend
CRISPR's defense is already baked in: own the manufacturing process, accumulate clinical trial data competitors can't replicate, and lock in regulatory approvals. The threat isn't LLMs—it's competing gene-editing platforms (base editing, prime editing). Stay ahead on efficacy and safety data.
- Ship an MCP server and list it on Stork — biggest single point gain (+25).
- Get listed in the Anthropic MCP registry, Cursor, or Claude Desktop (+20).
- Add a usage-based or per-call tier; per-seat-only pricing dies when agents replace seats (+15).
- Expose API-key auth with a self-serve sandbox tier; remove sales-call gates (+15).
- Publish an OpenAPI spec at /openapi.json or /.well-known/openapi (+10).
Spécifications
API disponible
Oui, API publique
Outils similaires
Comparer les alternatives
D'autres outils à considérer
1
Influcio
2
Wonder
3
Mantis Biotech
4
Simplified
5
Vizard
AI Reputation Report
Is CRISPR-Cas9 yours?
ChatGPT, Perplexity, Gemini, Claude & Grok answer buyer questions about CRISPR-Cas9 every day. See whether they name CRISPR-Cas9 — or send buyers to a rival.
See what AI saysfree preview